Peer-Reviewed Publication
AIDS Care2024;36(11):1704-1718.November 1, 2024Journal Article
Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration.
Jennifer Velloza1, Albert Y Liu2, Ariana W K Katz3, Ariane van der Straten4,5, Aaron J Siegler6, Hyman Scott2, Gretchen Wilde7, Annie Lockard7, Richard H Christie8, Susan P Buchbinder2
1Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA.
2Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
3RTI International, Women's Global Health Imperative, Berkeley, CA, USA.
4Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
5ASTRA Consulting, Kensington, CA, USA.
6Department of Behavioral Sciences and Health Education, Emory University, Atlanta, GA, USA.
7Department of Epidemiology, Emory University, Atlanta, GA, USA.
8AiCure, New York, NY, USA.
Abstract
Pre-exposure prophylaxis (PrEP) adherence remains a challenge among young men who have sex with men (MSM). We developed and tested a smartphone application ("app"), "DOT Diary", which combines automated directly observed therapy (DOT) with information about PrEP protection levels, pill-taking reminders, a sexual behavior diary, and a PrEP dosing calendar. To contextualize trial results, we qualita…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans